Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
Active & Responsive
A Study of Brenipatide in Participants With Opioid Use Disorder
for
Opioid Use Disorder
Location: Rockville MD, Baltimore MD, Charlottesville VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07420283
Phase 2, Recruiting
Active & Responsive
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for
Alcohol Use Disorder
Location: Rockville MD, Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07219966
Phase 3, Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: College Park MD, New York NY, Chapel Hill NC,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase 1, Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Falls Church VA, Olney MD, Oxon Hill MD, Manassas VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
MDMA Therapy in Veterans With PTSD
for
Post Traumatic Stress Disorder
Location: Rockville MD
Sponsor: Sunstone Medical
Sex: All
Age: 18+
Code: NCT07569159
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
for
Cancer, Adjustment Disorders
Location: Rockville MD
Sponsor: Sunstone Medical
Sex: All
Age: 18+
Code: NCT05584826
Phase 2, Recruiting
Active & Responsive
Pragmatic Trial of Psilocybin Therapy in Palliative Care
for
Demoralization
Location: Rockville MD, Torrance CA, Los Angeles CA,
Sponsor: Charles S. Grob, M.D.
Sex: All
Age: 18+
Code: NCT05403086
Phase 2, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Rockville MD, Fairfax VA, Richmond VA, Bethlehem PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
for
Post Traumatic Stress Disorder, PTSD
Location: Rockville MD
Sponsor: Sunstone Medical
Sex: Female
Age: 18+
Code: NCT06902974
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Rockville MD, Duncansville PA, Willow Grove PA,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
Fertilo In Vitro Research Study and Trial
for
In Vitro Maturation of Oocytes
Location: Rockville MD, New York NY, Raleigh NC, Charlotte NC,
Sponsor: Gameto, Inc.
Sex: Female
Age: 18 - 35
Code: NCT06858111
Phase 3, Recruiting
Active & Responsive
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
for
Fertility Preservation
Location: Rockville MD, Orange CT
Sponsor: Shady Grove Fertility Reproductive Science Center
Sex: Female
Age: 18 - 40
Code: NCT07225660
Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: Rockville MD, Norfolk VA, The Bronx NY, Mississauga,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Rockville MD, Plymouth Meeting PA, East Windsor NJ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: Gaithersburg MD, Marlton NJ, Staten Island NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06929273
Phase 3, Recruiting
Active & Responsive
52-week Open Label Safety-Tolerability Study
for
Schizophrenia
Location: Gaithersburg MD, Philadelphia PA, New York NY,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07369154
Phase 3, Recruiting
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Gaithersburg MD, New York NY, Cedarhurst NY,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06966401
Phase 3, Recruiting
Active & Responsive
ACP-204 in Adults With Alzheimer's Disease Psychosis